Furthermore, EGF signaling can block the release of immunomodulatory cytokines that promote T cell infiltration in HNSCC (92), whereas pharmacological inhibition of EGFR promotes the infiltration of cytotoxic (CD8+) T cells in a murine model of HNSCC (93). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.